Chesley Taft & Associates LLC Regeneron Pharmaceuticals, Inc. Transaction History

Chesley Taft & Associates LLC

$2.08 Billion
Q3 2024

A detailed history of Chesley Taft & Associates LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Chesley Taft & Associates LLC holds 485 shares of REGN stock, worth $367,052. This represents 0.02% of its overall portfolio holdings.

Number of Shares

485

Previous 485 -0.0%

Holding current value

$367,052

Previous $509,000 -0.0%

% of portfolio

0.02%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 13, 2022	SELL	$573.97 - $724.32 $329,458 - $415,759	-574 Reduced 54.2%	485 $334,000
Q2 2022 Jul 07, 2022	BUY	$548.35 - $738.84 $16,450 - $22,165	30 Added 2.92%	1,059 $626,000
Q4 2021 Jan 05, 2022	BUY	$543.48 - $670.97 $57,608 - $71,122	106 Added 11.48%	1,029 $650,000
Q2 2021 Jul 07, 2021	SELL	$472.8 - $558.54 $26,004 - $30,719	-55 Reduced 5.62%	923 $516,000
Q1 2021 Apr 06, 2021	SELL	$446.73 - $548.2 $87,112 - $106,899	-195 Reduced 16.62%	978 $474,000
Q3 2020 Oct 08, 2020	SELL	$544.75 - $658.21 $163,425 - $197,463	-300 Reduced 20.37%	1,173 $657,000
Q1 2020 Apr 15, 2020	BUY	$336.18 - $494.43 $16,809 - $24,721	50 Added 3.51%	1,473 $719,000
Q4 2019 Jan 10, 2020	SELL	$274.13 - $376.51 $8,772 - $12,048	-32 Reduced 2.2%	1,423 $534,000
Q3 2019 Oct 07, 2019	BUY	$273.46 - $318.39 $48,402 - $56,355	177 Added 13.85%	1,455 $404,000
Q2 2019 Jul 10, 2019	SELL	$299.6 - $414.82 $760,085 - $1.05 Million	-2,537 Reduced 66.5%	1,278 $400,000
Q1 2019 Apr 05, 2019	SELL	$372.08 - $439.57 $13,766 - $16,264	-37 Reduced 0.96%	3,815 $1.57 Million
Q4 2018 Jan 07, 2019	SELL	$335.82 - $403.04 $182,686 - $219,253	-544 Reduced 12.37%	3,852 $1.44 Million
Q2 2018 Jul 12, 2018	SELL	$284.6 - $344.99 $36,998 - $44,848	-130 Reduced 2.87%	4,396 $1.52 Million
Q1 2018 Apr 11, 2018	SELL	$315.82 - $393.78 $23,370 - $29,139	-74 Reduced 1.61%	4,526 $1.56 Million
Q3 2017 Oct 13, 2017	BUY	$431.38 - $504.0 $1.98 Million - $2.32 Million	4,600	4,600 $2.06 Million

Others Institutions Holding REGN

# of Institutions

1,529

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $81.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesley Taft & Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chesley Taft & Associates LLC with notifications on news.

Account

Chesley Taft & Associates LLC Regeneron Pharmaceuticals, Inc. Transaction History